Switching clinically eligible patients from IV to oral medications can lower the yearly cost of healthcare, according to a recent study published online in Clinical Therapeutics.
Researchers from the Johns Hopkins University School of Medicine in Baltimore reviewed four costly medications and determined that the potential impact on hospital savings could be substantial.
Further details and the abstract are available at: http://www.mdnews.com/news/hd/2011_45/hd_658375
Sources: Clinical Therapeutics, HealthDay, MD News
Strategies Needed to Address Physical Activity Before, After CVD Events
August 1st 2025Black women had lower moderate-to-vigorous intensity physical activity scores when compared with Black and White men and their White female counterparts, highlighting the need for support across patient subgroups.
Read More
Prenatal PFAS Exposure Alters Infant Vaccine-Related Immune Cells
August 1st 2025Prenatal exposure to per- and polyfluoroalkyl substances (PFAS), a class of persistent environmental pollutants, was linked to significant shifts in infant T helper cell development, raising concerns about long-term effects on vaccine response, immune regulation, and disease susceptibility.
Read More